Stockreport

Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Upstream Bio, Inc.  (UPB) 
PDF – Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP – – Commenced startup for a Phase 2 clinical trial in COPD; on trac [Read more]